Table 1 CD3+ and TCRγδ + cell counts in CE cysts and tissue controls with/without Fasciola hepatica co-infection.
Study group | n | Area | CD3+ cells/mm2 count | TCRγδ + cells/mm2 count | TCRγδ+/CD3+ percentage (%) | |||
---|---|---|---|---|---|---|---|---|
Mean ± SD | P-value | Mean ± SD | P-value | Mean ± SD | P-value | |||
CE + FH- | 4 | AL-Inf | 2,323 ± 727 | 0.0264* | 620 ± 298 | 0.1478 | 26.1 ± 7.4 | 0.8278 |
AL-Fib | 1,088 ± 428 | 315 ± 21 | 27.4 ± 9.3 | |||||
CE + FH+ | 4 | AL-Inf | 2,154 ± 631 | 0.0048* | 314 ± 95 | 0.052 | 15.4 ± 5.8% | 0.5047 |
AL-Fib | 646 ± 284 | 135 ± 113 | 18.7 ± 7% | |||||
CTRL | 5 | AL-Inf | 340 ± 188 | 0.0168* | 12 ± 8 | 0.0019* | 3.7 ± 2.7% | 0.1032 |
AL-Fib | 800 ± 258 | 51 ± 18 | 6.6 ± 2.1% | |||||
FH+ | 5 | AL-Inf | 187 ± 72 | 0.0165 | 11 ± 7 | 0.0513 | 6 ± 3.2 | 0.0479* |
AL-Fib | 663 ± 345 | 79 ± 67 | 11.4 ± 4.1 |